Leaked news from the future.
Tap to receive
Johnson & Johnson will report Innovative Medicine revenue at or below $17.2 billion. With the company slated to report Q3 2026 on October 13, 2026, a miss would line up with Wall Street consensus near $16.59 billion and the $16.384 billion reported in Q2 2026. Management will point to offsets such…